These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22925480)

  • 1. Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study.
    Blumentals WA; Arreglado A; Napalkov P; Toovey S
    BMC Musculoskelet Disord; 2012 Aug; 13():158. PubMed ID: 22925480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.
    Germano V; Cattaruzza MS; Osborn J; Tarantino A; Di Rosa R; Salemi S; D'Amelio R
    J Transl Med; 2014 Mar; 12():77. PubMed ID: 24655394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis.
    Desai RJ; Rao JK; Hansen RA; Fang G; Maciejewski ML; Farley JF
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1110-20. PubMed ID: 25351972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of influenza vaccination in patients with rheumatoid arthritis.
    Chen CM; Chen HJ; Chen WS; Lin CC; Hsu CC; Hsu YH
    Int J Rheum Dis; 2018 Jun; 21(6):1246-1253. PubMed ID: 29879317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).
    Nguyen M; Lindegaard H; Hendricks O; Friis-Møller N
    Scand J Rheumatol; 2017 Nov; 46(6):446-453. PubMed ID: 28145151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study.
    Huang Y; Agarwal SK; Chatterjee S; Chen H; Johnson ML; Aparasu RR
    Clin Rheumatol; 2024 Jan; 43(1):103-116. PubMed ID: 37540382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary tract infections in patients with rheumatoid arthritis.
    Puntis D; Malik S; Saravanan V; Rynne M; Heycock C; Hamilton J; Kelly CA
    Clin Rheumatol; 2013 Mar; 32(3):355-60. PubMed ID: 23238605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.
    Boytsov NN; Bhattacharya R; Saverno K; Dixon L; Abbott PL; Zhang X; Gaich CL; Nair R
    J Manag Care Spec Pharm; 2019 Aug; 25(8):879-887. PubMed ID: 31347977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort.
    Kobashigawa T; Nakajima A; Taniguchi A; Inoue E; Tanaka E; Momohara S; Yamanaka H
    Scand J Rheumatol; 2013; 42(6):445-50. PubMed ID: 23724971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.
    Costello R; Winthrop KL; Pye SR; Brown B; Dixon WG
    PLoS One; 2016; 11(4):e0153848. PubMed ID: 27096429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population.
    Crane MM; Juneja M; Allen J; Kurrasch RH; Chu ME; Quattrocchi E; Manson SC; Chang DJ
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1646-55. PubMed ID: 26097059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis.
    Jain VK; Bhashini N; Balajee LK; Sistla S; Parija SC; Negi VS
    Indian J Med Res; 2017 Apr; 145(4):464-470. PubMed ID: 28862177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis.
    Meissner Y; Zink A; Kekow J; Rockwitz K; Liebhaber A; Zinke S; Gerhold K; Richter A; Listing J; Strangfeld A
    Arthritis Res Ther; 2016 Aug; 18(1):183. PubMed ID: 27495156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs.
    Michel M; Vincent FB; Rio S; Leon N; Marcelli C
    Joint Bone Spine; 2016 Mar; 83(2):237-8. PubMed ID: 26190453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.